Additionally, the boom of excitement around generative AI has the biopharma industry questioning the relevant use cases and their impact.
Additionally, the boom of excitement around generative AI has the biopharma industry questioning the relevant use cases and their impact. So far, there has been significant activity in R&D applying gen AI to use cases such as accelerating drug discovery with de novo drug design across modalities and enhancing indication finding. But gen AI also presents opportunities to solve problems in other pharma domains—including commercial, medical, manufacturing, and other supporting functions—through use cases such as generating insights on patient and physician activity to refine the understanding of drug performance or improving patient experience with virtual support services.